Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adverse Events
Biotech
ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study
No grade 4 or 5 cases of cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome occurred.
Gabrielle Masson
May 31, 2025 7:00pm
Intellia stock sinks on gene therapy patient's raised enzymes
May 29, 2025 9:15am
Pliant terminates lung disease trial due to adverse events
Mar 3, 2025 11:30am
Cargo offloads CAR-T, 50% of staff over efficacy, side effects
Jan 30, 2025 8:05am
Keros ends hypertension trial over fluid buildups around heart
Jan 15, 2025 8:25am
Keros halts 2 arms of hypertension trial over fluid near heart
Dec 12, 2024 6:30am
